A precisely-formulated 5 mg dose of retatrutide, a novel triple agonist of the GLP-1, GIP, and glucagon receptors. Intended for research and clinical applications investigating metabolic regulation, weight management, and glycemic control.
In Stock
© 2026 SHOPPETIDES
